.svg){kind=small}
Nov-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Remedi's performance across various categories and states showcases a dynamic presence with notable movements. In Illinois, Remedi has shown consistent strength in the Capsules category, maintaining a steady rank around the top 5, although they dropped out of the top 30 in November. Their Tincture & Sublingual products have also demonstrated robust performance, improving from rank 4 to 3 from August to November, indicating growing consumer preference. However, it is worth noting that in the Concentrates category, while they managed to improve their ranking from 18th to 15th between September and November, the fluctuations suggest a competitive market environment.
In Massachusetts, Remedi's presence in the Concentrates category has been somewhat volatile. Despite an impressive climb from 27th in August to 15th in October, their rank dropped back to 25th in November. This could point to challenges in maintaining market share or increased competition. The sales data reflects these movements, with a peak in October followed by a decline in November, suggesting a potential seasonal or competitive impact. Such variations highlight the importance of strategic positioning and adaptation in different markets to sustain growth and rank stability.
Competitive Landscape
In the Illinois concentrates market, Remedi has shown a notable upward trajectory in its ranking and sales performance over the past few months. Starting from a rank of 17th in August 2024, Remedi experienced a slight dip to 18th in September and October, before climbing to 15th in November. This improvement in rank is mirrored by a significant increase in sales, particularly in November, where Remedi outperformed its previous months. In contrast, FloraCal Farms maintained a relatively stable position, fluctuating between 16th and 19th, while Grassroots and Mozey Extracts both experienced more consistent higher rankings, although Grassroots saw a drop to 14th in November. Meanwhile, Avexia held steady at 17th for most of the period. These dynamics suggest that Remedi's strategic initiatives might be yielding positive results, potentially positioning it for further gains in the competitive landscape.
Notable Products
In November 2024, the top-performing product for Remedi was the Indica Rest RSO Dropper (0.5g) in the Concentrates category, maintaining its first-place rank consistently from August through November, with a notable sales figure of 3154 units. The Indica Relief RSO Syringe (0.5g), also in the Concentrates category, secured the second rank throughout the same period, showing a steady increase in sales. The Indica Rest RSO Syringe (0.5g) held the third position consistently, reflecting stable performance. The CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) moved up to fourth place in November, improving from its fifth-place standing in previous months. Meanwhile, the CBD/THC 1:5 Rest Tincture (20mg CBD, 100mg THC, 30ml) re-entered the rankings at fifth place, indicating a resurgence in sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
